Dyne Therapeutics · 4 hours ago
Associate Director, US Marketing Operations
United States
Contract
Remote
Senior Level, Lead/Staff, Director/Executive
$155K/yr - $190K/yr
8+ years expDyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The Associate Director, US Marketing Operations will lead the tactical execution of marketing operations, focusing on launch readiness for therapeutic assets and driving operational excellence across various departments.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Commercial MLR Review Committee Leadership Chair the Dyne Commercial Medical, Legal, and Regulatory review committee and manage the end-to-end content review and approval process for Commercial-led therapeutic education
Partner closely with Marketing, Medical, Legal, and Regulatory teams to foster a collaborative, solution-oriented review culture
Ensure timely, compliant review of HCP, payer, and patient-facing materials and optimize systems supporting content workflows such as Veeva Vault PromoMats
Collaborate with Regulatory, Legal, and Compliance to maintain policies, procedures, and governance aligned with evolving regulatory standards
HCP and Consumer Engagement Design and implement a fit-for-purpose HCP and consumer peer-to-peer engagement model that meets the unique educational needs of rare disease launches in DMD and DM1
Oversee HCP and consumer engagement operations across the Commercial organization, including nomination, contracting, onboarding, training, logistics, and relationship management
Ensure compliance with all applicable industry regulations and internal policies, including fair market value requirements and Sunshine reporting
Marketing Excellence and Performance Serve as a strategic partner to Dyne Brand Teams, aligning Marketing Operations capabilities to commercial objectives to enhance executional effectiveness
Drive continuous improvement across marketing operations processes to support agility, scalability, and compliance
Oversee print fulfillment operations and manage promotional asset lifecycle planning
Partner with Commercial Operations, Information Technology, and Analytics teams to enable systems that track performance and integrate insights into campaign design and optimization
Ensure personalized and precise customer engagement through effective use of data, segmentation, and targeting strategies
Congress and Meeting Management Lead planning and execution of US HCP and consumer-facing congresses, conventions, and field-sponsored events to maximize Dyne’s presence and engagement impact
Partner closely with Marketing, field-facing teams, and Medical Affairs to coordinate KOL engagement strategies at congresses, ensuring operational excellence, brand alignment, and compliance
Qualification
Required
Bachelor's degree required
8+ years of experience in the pharmaceutical or biotechnology industry, with experience supporting rare disease or accelerated approval launches preferred
Demonstrated ability to thrive in fast-paced environments with strong prioritization and problem-solving skills
Proactive, adaptable, and solution oriented, with a track record of delivering results under tight timelines
Proven experience leading promotional review processes in regulated environments
Deep understanding of US regulatory requirements and compliance standards governing promotional activity
Excellent communication, interpersonal, and stakeholder management skills
Strong business acumen with the ability to translate strategic objectives into operating execution
Preferred
advanced degree such as MBA or MPH preferred
Experience with commercial systems and platforms such as Veeva Vault PromoMats highly preferred
Experience operating effectively in a small, rapidly growing biotech environment with comfort navigating ambiguity
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Leadership Team
John Cox
Chief Executive Officer
Recent News
2026-01-11
2026-01-07
2025-12-24
Company data provided by crunchbase